date:Oct 15, 2012
ck adenosine receptors has been linked to cognitive improvement in certain neurodegenerative diseases and as a protectant against Alzheimers disease.
We feel that our foot is in the door now, and this research may lead to a way to reverse early cognitive impairment in the brain. We already have drugs that target certain adenosine receptors. Our work now is to determine which receptor is the most important and use a specific antagonist to that receptor, concluded Freund.